ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996

UCLA, NYU Get Money, Near comprehensive Identification

May 30, 1975

Institute of Medicine Elects 70 Members at Annual Meeting

October 25, 2013

CPRIT Executive Director Bill Gimson Is Out As Scandal Grows, Investigations Begin

December 14, 2012

Bypass Budget for FY 1989 to Ask $2 Billion For NCI, With Projection To $3 Billion by 1993

May 29, 1987

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003